← Back to Search

Smartphone-Assisted Relapse Prevention for Substance Use Disorder (SARC-YA Trial)

N/A
Recruiting
Led By Michael L Dennis, Ph.D.
Research Sponsored by Chestnut Health Systems
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 to 26 at the time of discharge
Be between 18 and 65 years old
Must not have
Inability to read and communicate in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months sfs minus 6 month sfs
Awards & highlights

Summary

This trial will test whether providing young adults in outpatient treatment for substance abuse with a smartphone, data plan, and access to recovery-focused applications will help them to stay away from substance abuse better than without the phone.

Who is the study for?
This trial is for young adults aged 18-26 who are being discharged from outpatient substance use disorder treatment and have used substances within the last 90 days. They must be able to read and communicate in English and plan to stay in Chicago for the next 9 months.Check my eligibility
What is being tested?
The study compares usual recovery support with a new method using smartphones (SARC-YA) after treatment discharge. Participants will get a smartphone, data plan, apps for daily assessments, feedback, behavioral tracking, and self-help tools to prevent relapse.See study design
What are the potential side effects?
There may not be traditional medical side effects; however, participants might experience stress or anxiety from constant monitoring or reliance on digital devices which could impact their mental health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 26 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot read or communicate in English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months sfs minus 6 month sfs
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months sfs minus 6 month sfs for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in GAIN's Substance Frequency Scale from baseline to 6 months (effect of providing the intervention)
Secondary outcome measures
Change in European Quality of Life 5 dimensions (EQ5D) from baseline to 6 months
Change in GAIN Risk Behavior Screener (RBScr) from baseline to 6 months
Change in GAIN Substance Disorder Screener (SDScr) from baseline to 6 months
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smartphone Addiction Recovery Coach (SARC) - Assisted Relapse PreventionExperimental Treatment1 Intervention
Participants in the experimental condition will receive a smartphone, a calling/texting/data plan, and the SARC-YA mobile applications for the first 6 months post treatment discharge. Experimental participants will 1) complete a 2-3 minute recovery-focused ecological momentary assessment (EMA) at 5 random times a day, receive feedback on their current answers, and provided access to behavioral charting of their past answers over time; and 2) receive continuous access to a suite of self-initiated ecological momentary interventions (EMI) to support their recovery via tool box of coping tools, apps related to getting support, and apps related to maintaining a healthy lifestyle.
Group II: Recovery Support as Usual ControlActive Control2 Interventions
Participants in the control and experimental condition will have access to post treatment recovery support services as usual.

Find a Location

Who is running the clinical trial?

Chestnut Health SystemsLead Sponsor
22 Previous Clinical Trials
23,113 Total Patients Enrolled
Michael L Dennis, Ph.D.Principal InvestigatorChestnut Health Systems
2 Previous Clinical Trials
1,285 Total Patients Enrolled

Media Library

Smartphone assisted relapse prevention Clinical Trial Eligibility Overview. Trial Name: NCT03301012 — N/A
Substance Use Disorder Research Study Groups: Smartphone Addiction Recovery Coach (SARC) - Assisted Relapse Prevention, Recovery Support as Usual Control
Substance Use Disorder Clinical Trial 2023: Smartphone assisted relapse prevention Highlights & Side Effects. Trial Name: NCT03301012 — N/A
Smartphone assisted relapse prevention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03301012 — N/A
~40 spots leftby Feb 2025